Stock Trend Analysis Report
Prepared for you on Monday, December 2, 2024.
Celldex Therapeutics, Inc. (NASDAQ:CLDX)
Strong Uptrend (+100) - CLDX is in a strong uptrend that is likely to continue. With short-term, intermediate, and long-term bullish momentum, CLDX continues to climb. Traders should protect gains and look for a change in score to suggest a slow down in momentum.
Is it time to buy, sell, or avoid CLDX?
MarketClub looks at technical strength and momentum to determine if the timing is right for CLDX.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
MarketClub’s Trade Triangles for CLDX
The long-term trend has been UP since Sep 25th, 2024 at 46.8600
The intermediate-term trend has been UP since Nov 25th, 2024 at 28.1499
The short-term trend has been UP since Nov 20th, 2024 at 25.8900
Smart Scan Analysis for CLDX
Based on our trend formula, CLDX is rated as a +100 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
Open | High | Low | Price | Change |
---|---|---|---|---|
27.820 | 27.820 | 27.025 | 27.445 | -0.445 |
Prev. Close | Volume | Bid | Ask | Time |
27.440 | 132462 | 2024-11-29 12:59:17 |
Year High | 3.08 | Year High Date | 2018-01-04 |
Year Low | 0.282 | Year Low Date | 2018-11-27 |
52wk High | 53.18 | 52wk High Date | 2024-03-04 |
52wk Low | 22.9291 | 52wk Low Date | 2024-11-18 |
Year End Close | 6.71 | Average Volume | 1,121,938 |
Shares Outstanding | 66,288 | Short Interest | 5,704,808 |
% Institutional | 63.2 | Market Cap | 34M |
Assets | 823,179,000M | Liabilities | 37,274,000M |
Beta | 2.87 | Volatility | 75.78 |